Abstract
On average 20–30% of patients with non muscle-invasive bladder cancer will develop muscle-invasive disease with approximately 50% already having regional or distant metastases (Merseburger et al. in Curr Opin Urol 18(5): 513–518, 2008). Few interdisciplinary centres are demonstrating multimodality bladder sparing approaches as equally effective when compared with radical cystectomy for muscle-invasive bladder cancer (Merseburger et al. in Curr Opin Urol 18(5): 513–518, 2008). This chapter deals with endoscopic resection.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Leliveld AM, Bastiaannet E, Doornweerd BH, Schaapveld M, de Jong IJ. High risk bladder cancer: current management and survival. Int Braz J Urol. 2011;37(2):203–10.
Merseburger AS, Matuschek I, Kuczyk MA. Bladder preserving strategies for muscle-invasive bladder cancer. Curr Opin Urol. 2008;18(5):513–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Goonewardene, S.S., Persad, R., Motiwala, H., Albala, D. (2020). NMIBC and Oncological Outcomes from Endoscopic Resection. In: Management of Non-Muscle Invasive Bladder Cancer. Springer, Cham. https://doi.org/10.1007/978-3-030-28646-0_21
Download citation
DOI: https://doi.org/10.1007/978-3-030-28646-0_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-28645-3
Online ISBN: 978-3-030-28646-0
eBook Packages: MedicineMedicine (R0)